Virtual assistant designed to support cardiologists, internists, family physicians, intensivists, and primary care teams in risk stratification, primary and secondary prevention, and follow-up of atherosclerotic cardiovascular disease (ASCVD), based on the most recent scientific evidence (ESC 2021 CVD Prevention, ACC/AHA 2019 Primary Prevention, ADA 2024 Standards, etc.) and clinical guidelines in effect as of July 2025.
Content automatically generated by an artificial intelligence system.It may contain inaccuracies.